BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17340305)

  • 1. The Structure of New Valepotriates from Tissue Cultures of Valeriana wallichii.
    Becker H; Chavadej S; Thies PW; Firmer E
    Planta Med; 1984 Jun; 50(3):245-8. PubMed ID: 17340305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPCL Separation and quantitative determination of valepotriates from Valeriana kilimandascharica.
    Dossaji SF; Becker H
    Planta Med; 1981 Oct; 43(2):179-82. PubMed ID: 17402032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of storage time and conditions on the diene valepotriates content of the extract of Valeriana glechomifolia obtained by supercritical carbon dioxide.
    Müller LG; de Andrade Salles L; Sakamoto S; Stein AC; Cargnin ST; Cassel E; Vargas RF; Rates SM; von Poser GL
    Phytochem Anal; 2012; 23(3):222-7. PubMed ID: 21953720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic potential of valerian constituents and valerian tinctures.
    Bos R; Hendriks H; Scheffer JJ; Woerdenbag HJ
    Phytomedicine; 1998 May; 5(3):219-25. PubMed ID: 23195845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valepotriate content in different in vitro cultures of Valerianaceae and characterization of Valeriana officinalis L. callus during a growth period.
    Violon C; Van Cauwenbergh N; Vercruysse A
    Pharm Weekbl Sci; 1983 Oct; 5(5):205-9. PubMed ID: 6646985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-yield production of valepotriates by hairy root cultures of Valeriana officnalis L. var. sambucifolia Mikan.
    Gränicher F; Christen P; Kapetanidis I
    Plant Cell Rep; 1992 Jul; 11(7):339-42. PubMed ID: 24201434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valepotriate production of normal and colchicine-treated cell suspension cultures of Valeriana wallichii.
    Becker H; Chavadej S
    J Nat Prod; 1985; 48(1):17-21. PubMed ID: 4009183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorbifolivaltrates A-D, diene valepotriates from Valeriana sorbifolia(1).
    Xu YM; McLaughlin SP; Gunatilaka AA
    J Nat Prod; 2007 Dec; 70(12):2045-8. PubMed ID: 18052324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of valepotriates by hairy root cultures of Centranthus ruber DC.
    Gränicher F; Christen P; Kapétanidis I
    Plant Cell Rep; 1995 Feb; 14(5):294-8. PubMed ID: 24186763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of development and valepotriate production by auxins in micropropagated Valeriana glechomifolia.
    Bello de Carvalho CM; Maurmann N; Luz DI; Fett-Neto AG; Rech SB
    Plant Cell Rep; 2004 Oct; 23(4):251-5. PubMed ID: 15252693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of valepotriates from Valeriana native to South Brazil.
    Silva AL; Rech SB; von Poser GL
    Planta Med; 2002 Jun; 68(6):570-2. PubMed ID: 12094311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary metabolites from the underground parts of Valeriana sisymbriifolia Vahl. and their in vitro cytotoxic activities.
    Erdoğan M; Aru B; Yılmaz ŞT; Yeşilada E; Yanıkkaya-Demirel G; Kırmızıbekmez H
    Phytochemistry; 2023 Apr; 208():113590. PubMed ID: 36696936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of the structure-antioxidant activity relationships and antioxidant activity mechanism of iridoid valepotriates and their degradation products.
    Wang F; Zhang Y; Wu S; He Y; Dai Z; Ma S; Liu B
    PLoS One; 2017; 12(12):e0189198. PubMed ID: 29232391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antispasmodic effects of valeriana compounds: an in-vivo and in-vitro study on the guinea-pig ileum.
    Hazelhoff B; Malingré TM; Meijer DK
    Arch Int Pharmacodyn Ther; 1982 Jun; 257(2):274-87. PubMed ID: 7114974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of valtrate and isovaltrate by means of preparative liquid chromatography.
    Hazelhoff B; Jellema R; Grobben H; Malingré TM
    Pharm Weekbl Sci; 1982 Feb; 4(1):21-4. PubMed ID: 7070947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valerian-derived sedative agents. I. On the structure and spectral assignment of the constituents of valmane using the selective INEPT nuclear magnetic resonance technique.
    Lin LJ; Cordell GA; Balandrin MF
    Pharm Res; 1991 Sep; 8(9):1094-102. PubMed ID: 1788154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [RP-8 Auxiliary Phase for the Accumulation of Valepotriates from Cell-Suspension-Culture of Valeriana wallichii.].
    Becker H; Herold S
    Planta Med; 1983 Nov; 49(11):191-2. PubMed ID: 17405049
    [No Abstract]   [Full Text] [Related]  

  • 18. Minor iridoids from the roots of Valeriana wallichii.
    Wang R; Xiao D; Bian YH; Zhang XY; Li BJ; Ding LS; Peng SL
    J Nat Prod; 2008 Jul; 71(7):1254-7. PubMed ID: 18557641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Plant Bioregulators on Valepotriate Production of Cell Suspension Cultures of Valeriana wallichii and Fedia cornucopiae.
    Förster W; Becker H
    Planta Med; 1986 Dec; (6):510. PubMed ID: 17345436
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preparation of 14C-administrated valepotriates with Valeriana wallichii (author's transl)].
    Hölzl J
    Planta Med; 1973 Aug; 24(1):66-72. PubMed ID: 4779640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.